Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung

[1] Siegel RL(2019)Cancer statistics, 2019 CA-Cancer J Clin 69 7-34

[2] Miller KD(2018)The biology and management of non-small cell lung cancer Nature. 553 446-454

[3] Jemal A(2015)Refining the treatment of NSCLC according to histological and molecular subtypes Nat Rev Clin Oncol 12 511-526

[4] Herbst RS(2017)The eighth edition lung cancer stage classification Chest. 151 193-203

[5] Morgensztern D(2019)The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer J Surg Oncol 119 379-387

[6] Boshoff C(2011)What’s new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements Pathology. 43 103-115

[7] Thomas A(2017)EGFR mutation subtypes influence survival outcomes’ following first-line gefitinib therapy in advanced Asian NSCLC patients J Thorac Oncol 12 529-538

[8] Liu SV(2016)Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure Cancer Cytopathol 124 737-743

[9] Subramaniam DS(2003)Guidelines for radiologically guided lung biopsy Thorax. 58 920-936

[10] Giaccone G(2016)Image-guided biopsy in primary lung cancer: why, when and how Diagn Interv Imaging 97 965-972

[1] Siegel RL(2019)Cancer statistics, 2019 CA-Cancer J Clin 69 7-34

[2] Miller KD(2018)The biology and management of non-small cell lung cancer Nature. 553 446-454

[3] Jemal A(2015)Refining the treatment of NSCLC according to histological and molecular subtypes Nat Rev Clin Oncol 12 511-526

[4] Herbst RS(2017)The eighth edition lung cancer stage classification Chest. 151 193-203

[5] Morgensztern D(2019)The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer J Surg Oncol 119 379-387

[6] Boshoff C(2011)What’s new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements Pathology. 43 103-115

[7] Thomas A(2017)EGFR mutation subtypes influence survival outcomes’ following first-line gefitinib therapy in advanced Asian NSCLC patients J Thorac Oncol 12 529-538

[8] Liu SV(2016)Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure Cancer Cytopathol 124 737-743

[9] Subramaniam DS(2003)Guidelines for radiologically guided lung biopsy Thorax. 58 920-936

[10] Giaccone G(2016)Image-guided biopsy in primary lung cancer: why, when and how Diagn Interv Imaging 97 965-972